Bank Julius Baer & Co
EW icon

Bank Julius Baer & Co’s Edwards Lifesciences EW Stock Holding History

Bank Julius Baer & Co’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.62M Sell
51,018
-19,969
-28% -$1.67M 0.01% 263
2026
Q1 		$5.66M Sell
70,987
-2,629
-4% -$217K 0.02% 223
2025
Q4 		$6.33M Buy
73,616
+60,588
+465% +$4.97M 0.02% 217
2025
Q3 		$1.01M Sell
13,028
-99,293
-88% -$7.76M ﹤0.01% 371
2025
Q2 		$8.78M Sell
112,321
-28,861
-20% -$2.15M 0.03% 197
2025
Q1 		$10.2M Buy
141,182
+13,746
+11% +$984K 0.03% 188
2024
Q4 		$10.4M Buy
127,436
+31,972
+33% +$2.24M 0.03% 201
2024
Q3 		$7.56M Sell
95,464
-837,997
-90% -$60.9M 0.03% 210
2024
Q2 		$93.9M Sell
933,461
-60,713
-6% -$5.38M 0.36% 66
2024
Q1 		$94.8M Buy
994,174
+33,213
+3% +$2.79M 0.36% 72
2023
Q4 		$73.3M Buy
960,961
+168,350
+21% +$11.7M 0.31% 81
2023
Q3 		$54.9M Buy
792,611
+33,296
+4% +$2.68M 0.32% 74
2023
Q2 		$71.6M Sell
759,315
-8,164
-1% -$710K 0.43% 59
2023
Q1 		$63.5M Sell
767,479
-7,455
-1% -$586K 0.4% 66
2022
Q4 		$57.8M Sell
774,934
-18
-0% -$1.39K 0.39% 64
2022
Q3 		$64M Sell
774,952
-43,197
-5% -$4.16M 0.49% 54
2022
Q2 		$77.8M Sell
818,149
-977,446
-54% -$101M 0.55% 44
2022
Q1 		$211M Buy
1,795,595
+46,253
+3% +$5.19M 1.27% 22
2021
Q4 		$227M Buy
1,749,342
+182,080
+12% +$21.2M 1.21% 23
2021
Q3 		$177M Buy
1,567,262
+189,189
+14% +$21.6M 1.1% 25
2021
Q2 		$143M Buy
1,378,073
+400,567
+41% +$37.8M 0.91% 30
2021
Q1 		$81.8M Sell
977,506
-233,992
-19% -$19.8M 0.61% 43
2020
Q4 		$111M Buy
1,211,498
+171,479
+16% +$14.2M 0.91% 27
2020
Q3 		$83M Buy
1,040,019
+128,744
+14% +$10M 0.81% 34
2020
Q2 		$63M Buy
911,275
+74,668
+9% +$5.31M 0.73% 38
2020
Q1 		$52.4M Buy
+836,607
New +$60.3M 1.21% 20

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Bank Julius Baer & Co's EW Position: Q2 2026 in Review

Bank Julius Baer & Co reduced its Edwards Lifesciences (EW) stake by 28% in Q2 2026, selling an estimated $1.67M and leaving 51,018 shares worth $4.62M. The position accounts for 0.01% of the portfolio, ranked #263.

Bank Julius Baer & Co first reported a position in EW in Q1 2020 and has held it in 26 quarters since. The position peaked at $227M in Q4 2021. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Bank Julius Baer & Co held 51,018 shares of Edwards Lifesciences worth $4.62M as of Q2 2026.
  • Bank Julius Baer & Co sold 19,969 Edwards Lifesciences shares in Q2 2026, an estimated $1.67M.
  • Edwards Lifesciences made up 0.01% of Bank Julius Baer & Co's portfolio in Q2 2026, its #263 holding.
  • Bank Julius Baer & Co first reported a position in Edwards Lifesciences in Q1 2020 and has held it in 26 quarters since.
  • Bank Julius Baer & Co's Edwards Lifesciences position peaked at $227M in Q4 2021.
  • 1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Bank Julius Baer & Co's 13F filing for Q2 2026, filed 10 Aug 2026.